NO922945L - Pyrazolderivater - Google Patents
PyrazolderivaterInfo
- Publication number
- NO922945L NO922945L NO92922945A NO922945A NO922945L NO 922945 L NO922945 L NO 922945L NO 92922945 A NO92922945 A NO 92922945A NO 922945 A NO922945 A NO 922945A NO 922945 L NO922945 L NO 922945L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- treatment
- pyrazole
- consciousness
- bromine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Pyrazolderivat med formelen I .N. d) hvor R., er X^V og R? er hydrogen, eller R. N l CH3 hvor n er l eller 2 og R, er hydrogen eller halogen; og R^ er brom eller jod; eller et farmasøytisk tilfredsstillende salt derav. Forbindelsene har muskarin-egenskaper og kan anvendes for behandling av bevissthetsforstyrrelser, som smertestillende midler og for behandling av kolinergiske mangler.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91306870 | 1991-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO922945D0 NO922945D0 (no) | 1992-07-24 |
NO922945L true NO922945L (no) | 1993-01-27 |
Family
ID=8208356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92922945A NO922945L (no) | 1991-07-26 | 1992-07-24 | Pyrazolderivater |
Country Status (11)
Country | Link |
---|---|
US (1) | US5227394A (no) |
EP (1) | EP0525879A1 (no) |
JP (1) | JPH05213934A (no) |
KR (1) | KR930002322A (no) |
AU (1) | AU647357B2 (no) |
CA (1) | CA2074601A1 (no) |
FI (1) | FI923325A (no) |
IE (1) | IE922270A1 (no) |
MX (1) | MX9204370A (no) |
NO (1) | NO922945L (no) |
ZA (1) | ZA925523B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA000531B1 (ru) * | 1995-11-06 | 1999-10-28 | Х.Лундбекк А/С | Активное вещество при производстве фармацевтического препарата для лечения травматического повреждения головного мозга |
US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
PT1014974E (pt) | 1997-05-29 | 2004-12-31 | Lundbeck & Co As H | Tratamento da esquizofrenia e psicoses |
JP2005512974A (ja) * | 2001-10-17 | 2005-05-12 | ユ セ ベ ソシエテ アノニム | キヌクリジン誘導体、その調製方法、及びm2及び/又はm3ムスカリン受容体阻害剤としてのその使用 |
GB0127731D0 (en) * | 2001-11-20 | 2002-01-09 | Coin Controls | Coin handling apparatus |
FR2862647B1 (fr) | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
EP2023909B1 (en) * | 2006-05-04 | 2009-11-18 | Solvay Pharmaceuticals B.V. | Muscarinic agonists to treat impulse control disorders |
WO2012052412A1 (de) | 2010-10-22 | 2012-04-26 | Bayer Cropscience Ag | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
EP0307141B1 (en) * | 1987-09-10 | 1993-01-13 | MERCK SHARP & DOHME LTD. | Oxazoles and thiazoles for the treatment of senile dementia |
IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
EP0402056A3 (en) * | 1989-06-06 | 1991-09-04 | Beecham Group p.l.c. | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
DE69026197T2 (de) * | 1989-10-07 | 1997-01-09 | Beecham Group Plc | Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
-
1992
- 1992-07-10 IE IE227092A patent/IE922270A1/en not_active Application Discontinuation
- 1992-07-20 AU AU20417/92A patent/AU647357B2/en not_active Ceased
- 1992-07-21 FI FI923325A patent/FI923325A/fi not_active Application Discontinuation
- 1992-07-21 EP EP92202227A patent/EP0525879A1/en not_active Withdrawn
- 1992-07-22 ZA ZA925523A patent/ZA925523B/xx unknown
- 1992-07-23 JP JP4196915A patent/JPH05213934A/ja active Pending
- 1992-07-24 CA CA002074601A patent/CA2074601A1/en not_active Abandoned
- 1992-07-24 MX MX9204370A patent/MX9204370A/es unknown
- 1992-07-24 NO NO92922945A patent/NO922945L/no unknown
- 1992-07-25 KR KR1019920013402A patent/KR930002322A/ko not_active Application Discontinuation
- 1992-07-27 US US07/919,806 patent/US5227394A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX9204370A (es) | 1993-03-01 |
EP0525879A1 (en) | 1993-02-03 |
CA2074601A1 (en) | 1993-01-27 |
JPH05213934A (ja) | 1993-08-24 |
FI923325A (fi) | 1993-01-27 |
NO922945D0 (no) | 1992-07-24 |
KR930002322A (ko) | 1993-02-22 |
FI923325A0 (fi) | 1992-07-21 |
IE922270A1 (en) | 1993-01-27 |
AU647357B2 (en) | 1994-03-17 |
ZA925523B (en) | 1993-04-28 |
US5227394A (en) | 1993-07-13 |
AU2041792A (en) | 1993-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO163819C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav. | |
ES8604559A1 (es) | Un metodo para preparar derivados de piperazina | |
HU9301155D0 (en) | Methods for producing steroide derivatives and for their application in medical treatment | |
AU2001272666A1 (en) | 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission | |
ATE102930T1 (de) | Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend. | |
MY131641A (en) | Indoline derivatives, process of preparation and use | |
DK519985D0 (da) | Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater | |
NO922945L (no) | Pyrazolderivater | |
DK0526313T3 (da) | Nye ureaderivater, deres fremstilling og terapeutiske anvendelse | |
TW324009B (en) | Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor | |
NO913331L (no) | 4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser. | |
NO922521L (no) | Piperidinyletanolderivater med terapeutisk virkning | |
ES2043515A1 (es) | Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina. | |
NO952949L (no) | Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider | |
NO985063L (no) | Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr | |
ES8400384A1 (es) | Procedimiento para la preparacion de derivados de carbaciclina. | |
DE59202744D1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
ATE160567T1 (de) | Psoralen-derivate, deren herstellung und verwendung als arzneimittel | |
GR3006108T3 (no) | ||
ES465136A1 (es) | Procedimiento para la preparacion de nuevos derivados de he-lebrigenina | |
DK0434833T3 (da) | 9-fluor-prostaglandinderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske anvendelse | |
NO164170C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater. | |
ES465366A2 (es) | Un procedimiento de preparacion de derivados de metoxi-2- benzamidas. | |
MY104630A (en) | 4(1h) ouinoline derivatives |